A drug that makes the body more sensitive to insulin helped to relieve symptoms of chronic depression in people resistant to the hormone, according to a study by researchers at the at the Stanford University School of Medicine.
The 12-week, randomized, placebo-controlled study, to be published Nov. 18 in Psychiatry Research, involved patients whose symptoms of depression had failed to improve substantially, despite treatment, for at least six months leading up to the study's onset.